Dato Capt. Mahesan Subramaniam/LinkedIn
Feb 23, 2026, 17:46
Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
Mahesan Subramaniam, Co-Founder of United Health Tourism, shared a post on LinkedIn:
“Anger suppresses the immune system by triggering a ‘fight-or-flight’ response that floods the body with stress hormones like cortisol and adrenaline. While these hormones provide a short-term energy burst, they inhibit the production and activity of critical immune cells.
The physiological impact of anger can be broken down into several key pathways:
- Hormonal Inhibition: Elevated cortisol levels directly suppress the activity of white blood cells, including natural killer (NK) cells and lymphocytes, which are essential for fighting off viruses and abnormalities cells.
- Inflammatory Dysregulation: Anger increases the production of pro-inflammatory cytokine. Over time, this leads to chronic inflammation, which damages tissues and can trigger autoimmune disorders where the immune system attacks it own body.
- Antibody Reduction: Chronic hostility has been linked to a weakened ability to produce antibodies, increasing susceptibility to common infections like the cold or flu.
- Cellular ‘Freeze’ Response: In cases of trauma or suppressed rage, the body may stay in a constant state of alert, causing the immune system to eventually ‘collapse’ or become hyper-reactive.
While just one minute of anger can suppress the immune system, chronic or persistent anger is associated with slower wound healing, higher risks of heart disease, and a greater likelihood of developing autoimmune conditions like rheumatoid arthritis and lupus.”

Discover the latest in Hemostasis Today.
-
Jul 14, 2026, 19:35Daratumumab in Difficult-to-Treat iTTP: Updated Results from the International DarTTP Study
-
Jul 14, 2026, 17:1610 Posts Not To Miss from ISTH 2026, Part 3
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP
-
Jul 14, 2026, 14:51Nathan Connell: ISTH 2026 Highlights the Power of Lifelong Collaboration
-
Jul 14, 2026, 14:42Wolfgang Miesbach: VOYAGER1 Highlights Progress Toward Injection-Free Care in Hemophilia A
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026